Selected Noninvasive Markers in Diagnosing Liver Diseases

Area of Science:

• Hepatology
• Biomarker Research
• Clinical Diagnostics

Background:

• Liver cirrhosis is a significant health concern with various etiologies.
• Accurate prediction of liver disease and cirrhosis severity is crucial for patient management.
• Noninvasive markers offer a promising alternative to invasive diagnostic procedures.

Purpose of the Study:

• To assess the efficacy of Bonacini, King, and Göteborg University Cirrhosis Index (GUCI) scores.
• To determine if these scores can predict different types of liver disease.
• To evaluate their ability to reflect the clinical severity of liver cirrhosis.

Main Methods:

• Serum samples from 57 alcoholic cirrhosis, 30 nonalcoholic cirrhosis, and 22 toxic hepatitis (TH) patients were analyzed.
• Bonacini, King, and GUCI scores were calculated using established formulas.
• Patient data included liver disease type and Child-Pugh class for severity assessment.

Main Results:

• Bonacini and King scores showed significant differences between liver diseases.
• Scores were higher in alcoholic and nonalcoholic cirrhosis compared to TH.
• All tested scores correlated with liver damage severity, being higher in Child-Pugh class C than A or B.

Conclusions:

• Bonacini and King scores are valuable in distinguishing between different liver diseases.
• The evaluated noninvasive scores accurately reflect the severity of liver cirrhosis.
• These markers hold potential for noninvasive assessment in hepatology.